Next |
home / stock / bbi / bbi message board
Subject | By | Source | When |
---|---|---|---|
JUST IN: $BBI Brickell Biotech Announces Launch Date | whytestocks | investorshub | 11/18/2020 10:45:17 PM |
BREAKING NEWS: $BBI Are These Penny Stocks To | whytestocks | investorshub | 08/28/2020 8:00:13 PM |
fly Blackbird fly | Spruitenburg | investorshub | 04/17/2018 12:20:59 PM |
Starting to look good | Rampage123 | investorshub | 11/11/2017 3:25:50 PM |
1,25M Volume. Not that bad. | Peron | investorshub | 03/08/2016 3:19:26 PM |
anybody recognized +522%proven resources?!? | Peron | investorshub | 03/08/2016 2:04:02 PM |
522% RESOURCE INCREASE! | Peron | investorshub | 03/08/2016 10:55:18 AM |
Result from yesterdays board meeting: | Peron | investorshub | 03/08/2016 10:51:16 AM |
Hmmmmm, it's in the crapper since several months | PlanTrader | investorshub | 11/02/2015 7:25:00 PM |
Deal! lol | PlanTrader | investorshub | 05/27/2015 11:53:52 AM |
OK don't trust me lol | GurSarai | investorshub | 05/27/2015 4:00:04 AM |
OK then don't trust me | GurSarai | investorshub | 05/27/2015 3:54:26 AM |
I've heard trust me in the penny stocks | PlanTrader | investorshub | 05/26/2015 8:51:44 PM |
I put in 20 thousand over last week. | GurSarai | investorshub | 05/26/2015 12:40:34 PM |
Hopefully that's how it plays out. The way | PlanTrader | investorshub | 05/26/2015 12:36:18 PM |
People need to look at filings.. | GurSarai | investorshub | 05/25/2015 4:05:11 PM |
Even with that I think by just looking | GurSarai | investorshub | 05/22/2015 9:50:50 PM |
Based on what, the 3Q drilling program they | PlanTrader | investorshub | 05/22/2015 8:36:17 PM |
Adding 22K INTO BBI TOMM! This will RUN AGAIN!... | GurSarai | investorshub | 05/22/2015 7:11:00 AM |
It usually or always comes back to a | PlanTrader | investorshub | 03/11/2015 3:18:47 PM |
News, Short Squeeze, Breakout and More Instantly...
Brickell Biotech Inc. Company Name:
BBI Stock Symbol:
NYSE Market:
New name, logo, website, and branding reflect the Company’s strategic shift toward developing potentially groundbreaking autoimmune and inflammatory disease therapies Company to begin trading under new ticker symbol “FRTX” on September 8, 2022 Compan...
Phase 1 study of BBI-02 progressing well and expect to initiate MAD part of the study next month On track to report SAD and MAD topline results from BBI-02 Phase 1 study by early 2023 Development of BBI-10 and next-generation kinase inhibitors advancing through early precl...
BOULDER, Colo., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription therapeutics for the treatment of autoi...